(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.
Fig. 6. Sema4d-induced inhibition of ureteric branching morphogenesis requires
activation of the Rho-ROCK pathway. (A) Treatment with Sema4d leads
to activation of RhoA in mice metanephroi cultured at E14.5. Lysates of
kidneys treated with either Sema4d or mock medium for 5 hours were incubated
with RBD-coupled sepharose and the amount of RhoA was analysed by western
blotting with an anti-RhoA antibody. The amount of G
13 was comparable
in the two samples (internal control). (B-D) Typical examples of
anti-calbindin-stained metanephroi cultured with either Sema4d or mock medium
in the presence or absence of the ROCK inhibitor Y27632 (1 µM). In the
presence of 1 µM Y27632, Sema4d did not attenuate ureteric branching.
(E,F) Y27632 (3 µM) led to a hyperplasia and distortion of
ureteric structures (arrowheads), to a lesser extent in Sema4d-treated kidneys
than in mock-treated kidneys. (G-I) Higher magnification views of
phalloidin-stained ureteric tips in Sema4d- or mock-treated kidneys cultured
in the presence of 3 µM Y27632. The Y27632-induced distortion of apical
wedge cells and actin bundles and the increase in tip lumen occurs to a lesser
extent in Sema4d-treated kidneys in comparison with mock-treated kidneys.
(J,K) Quantitative summary of the effects of Y27632 at either 1
µM or 3 µM on Sema4d- or mock-treated metanephroi.
P<0.001 when compared with mock;
*P<0.05 when compared with mock or Sema4d alone; ANOVA
followed by post-hoc Fisher's test. Scale bars: 200 µm in B-F; 70 µm in
G-I.
